Zhejiang Tianyu Pharmaceutical Co., Ltd.
SZSE:300702.SZ
20.8 (CNY) • At close October 26, 2023
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 27.359 | -118.953 | 204.676 | 667.061 | 585.726 | 163.662 | 100.182 | 122.338 | 50.355 | 24.14 | 33.588 |
| Afschrijvingen & Amortisatie
| 305.126 | 254.94 | 193.418 | 136.095 | 101.178 | 82.791 | 76.454 | 62.945 | 51.316 | 41.992 | 11.027 |
| Uitgestelde Inkomstenbelasting
| -0.28 | -5.295 | 1.066 | 5.658 | 3.98 | -2.178 | -1.92 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| -34.674 | -1.914 | 30.574 | 6.873 | 12.688 | 9.123 | 0 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -595.85 | -339.681 | -722.019 | -185.734 | -308.7 | -222.346 | -145.003 | -36.002 | -101.159 | -14.138 | 0 |
| Vorderingen
| -242.675 | -269.465 | -315.073 | -326.321 | -82.409 | -186.876 | -79.437 | -12.164 | 0 | 0 | 0 |
| Voorraden
| -12.715 | -515.151 | -763.467 | -140.187 | -283.546 | -156.023 | -124.826 | -38.127 | -83.791 | -18.223 | 0 |
| Crediteuren
| -340.18 | 450.231 | 355.455 | 275.115 | 53.275 | 122.731 | 61.18 | 0 | 0 | 0 | 0 |
| Overig Werkkapitaal
| -34.674 | -5.295 | 1.066 | 5.658 | 3.98 | -66.323 | -20.177 | 2.125 | -17.368 | 4.085 | 0 |
| Overige Niet-Contante Posten
| 42.805 | 154.994 | 61.695 | 4.759 | 49.633 | 54.465 | 56.884 | 15.459 | 14.239 | 28.444 | -4.883 |
| Kasstroom uit Operationele Activiteiten
| -43.905 | -48.7 | -262.23 | 622.181 | 427.837 | 78.572 | 88.517 | 164.74 | 14.751 | 80.438 | 39.732 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -316.805 | -527.012 | -736.39 | -506.053 | -354.103 | -179.888 | -112.538 | -107.435 | -62.587 | -79.986 | -68.314 |
| Netto Overnames
| 3.905 | 4.112 | -5.645 | -37.699 | -8.36 | -6 | -49.973 | -25.722 | 0.168 | 0 | 0 |
| Aankoop van Beleggingen
| -7.5 | -25.5 | -70.7 | -10.676 | 0.867 | 0.164 | -0.5 | 0.331 | -1.26 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 10 | 0.389 | 67.838 | 45.554 | 5.07 | 13.79 | 2.794 | 0.011 | 3.276 | 0 | 0.183 |
| Overige Investeringsactiviteiten
| -34.604 | 27.193 | -57.478 | -8.426 | 196.831 | 80.468 | -291.883 | -0.669 | 3.425 | 8.352 | 1.894 |
| Kasstroom uit Investeringsactiviteiten
| -355.354 | -520.818 | -802.375 | -517.301 | -159.694 | -91.465 | -452.101 | -133.816 | -57.146 | -71.634 | -66.238 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| -504.788 | -752.92 | -489.258 | -255.594 | -810.07 | -587.581 | -712.414 | -609.311 | -450.807 | -473.352 | -453.121 |
| Uitgifte van Gewone Aandelen
| 0 | 58 | 0.237 | 0 | 3.335 | 34.188 | 609.869 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -58 | -0.237 | 0 | -0.449 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -51.116 | -34.798 | -96.658 | -91.098 | -27.334 | -36.607 | -53.598 | -45.619 | -25.067 | -38.789 | -40.364 |
| Overige Financieringsactiviteiten
| -90.317 | 1,341.677 | 831.351 | 1,361.035 | 378.11 | 766.853 | 1,195.499 | 630.257 | 538.737 | 449.2 | 513.838 |
| Kasstroom uit Financieringsactiviteiten
| 363.355 | 519.341 | 229.667 | 1,010.5 | -468.739 | 142.665 | 429.488 | -24.673 | 62.863 | -62.942 | 20.354 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| -1.891 | 12.932 | -6.147 | -20.527 | 3.975 | 3.716 | -1.783 | 4.656 | 2.643 | 0.593 | -5.029 |
| Netto Kasstroomverandering
| -37.795 | -37.245 | -841.086 | 1,094.852 | -196.621 | 133.489 | 64.12 | 10.907 | 23.111 | -53.544 | -11.181 |
| Kaspositie aan het Einde van de Periode
| 232.433 | 270.228 | 307.473 | 1,148.559 | 53.706 | 250.328 | 116.839 | 52.719 | 41.812 | 18.701 | 72.245 |